Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
Graph Databases in Pharma: Mapping Physician Networks and Identifying Influencers
Pharma teams often know individual doctors, but they may not understand how those doctors are connected. Graph databases solve this gap by mapping physician relationships, research collaborations, institutional networks, and influence pathways across the healthcare ecosystem.
AI Powered HCP Segmentation for Pharma Marketing Teams
Pharma marketing teams no longer need broad doctor lists. They need intelligent HCP segments that reflect how physicians prescribe, learn, engage, and respond across channels. AI-powered HCP segmentation helps teams move from static targeting to dynamic, behavior-based marketing.
Real Time Physician Intelligence Platforms for Pharma Commercial Teams
Pharma commercial teams do not only need more doctor data. They need real-time physician intelligence that shows what HCPs are doing now, what they are interested in, and when engagement is most relevant.
Predicting Physician Engagement Using Machine Learning in Pharma
Pharma companies do not just need to know which doctors exist in their database. They need to know which physicians are likely to engage, when they are likely to respond, and what type of communication will create value. Machine learning makes this prediction possible. Pharmaceutical companies are increasingly using machine learning to predict physician engagement in pharma as communication cha
AI to Prioritize HCP Outreach in Pharma Sales: Complete Guide
Pharma sales teams do not need longer target lists. They need smarter priority lists. AI helps commercial teams identify which HCPs are most relevant, most ready for engagement, and most likely to respond at the right time.
AI Omnichannel HCP Engagement Platform in Pharma: Complete Guide
Most pharma companies already use multiple engagement channels. The real challenge is that those channels rarely work together. An AI omnichannel HCP engagement platform solves this by connecting physician data,
IQVIA OneKey vs Building Your Own HCP Master Data Platform: What Pharma Teams Should Choose in 2026
Most pharma teams do not have a physician data problem because they lack data. They have a physician data architecture problem. The key question is whether external datasets like IQVIA OneKey are enough—or whether the organization needs its own HCP master data platform to power AI, CRM, and omnichannel engagement.
What Is the Next Best Action in Pharma Commercial Operations? A Practical Guide
Pharmaceutical commercial teams interact with healthcare professionals through many channels. Sales representatives conduct in person meetings with physicians. Marketing teams send digital communications such as email campaigns and educational content.
AI for KOL Identification in Pharma: How to Find Influential Physicians
Finding the right KOL is no longer about knowing the most famous doctor in a therapy area. In modern pharma, the real challenge is identifying which physicians truly influence research, clinical practice, peer networks, and treatment adoption. AI is making this process faster, deeper, and more objective.
How Often Should Pharma Teams Refresh Their HCP Database?
Most pharma companies think their HCP database is mostly accurate. In reality, even small data decay can silently break targeting, analytics, and compliance workflows. The question is not whether HCP data becomes outdated; the question is how quickly your team can detect and correct it.
What Is a GenAI Doctor Data Platform and Why Pharma Commercial Teams Are Adopting It
Pharma companies no longer need only doctor databases. They need doctor intelligence. A GenAI doctor data platform helps commercial teams move from static physician records to AI-powered insights that explain how HCPs engage, decide, and respond across channels.
Doctor Data Validation: The Critical Step Most Pharma Commercial Teams Skip
Most pharma commercial teams invest heavily in CRM platforms, targeting systems, and AI-driven engagement tools. But if the underlying physician data is inaccurate, every downstream decision becomes unreliable.